Pages that link to "Q90197782"
Jump to navigation
Jump to search
The following pages link to Next-generation regulatory T cell therapy (Q90197782):
Displaying 18 items.
- CoRESTed development of regulatory T cells (Q89991575) (← links)
- Beneficial and Detrimental Effects of Regulatory T Cells in Neurotropic Virus Infections (Q90047739) (← links)
- Targeting interleukin-10 signalling for cancer immunotherapy, a promising and complicated task (Q90227476) (← links)
- Suppression of age-related salivary gland autoimmunity by glycosylation-dependent galectin-1-driven immune inhibitory circuits (Q90244601) (← links)
- A Defect in Thymic Tolerance Causes T Cell-Mediated Autoimmunity in a Murine Model of COPA Syndrome (Q90537763) (← links)
- Recent advances in primary immunodeficiency: from molecular diagnosis to treatment (Q90746855) (← links)
- The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases (Q91973492) (← links)
- For antigen-specific effector or Foxp3+ regulatory T cell fate, cyclin-dependent kinases hold the trump card (Q92133059) (← links)
- Genetic Engineering of T Cells for Immune Tolerance (Q92622092) (← links)
- Cell-in-Cell Structures in the Liver: A Tale of Four E's (Q96303574) (← links)
- Emerging routes to the generation of functional β-cells for diabetes mellitus cell therapy (Q96686040) (← links)
- From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer Treatment (Q98177704) (← links)
- Characterization of KIR + NKG2A + Eomes- NK-like CD8+ T cells and their decline with age in healthy individuals (Q98648535) (← links)
- Treg Enhancing Therapies to Treat Autoimmune Diseases (Q99726047) (← links)
- Functional CRISPR dissection of gene networks controlling human regulatory T cell identity (Q100316586) (← links)
- Cross talk between human regulatory T cells and antigen presenting cells: Lessons for clinical applications (Q104264527) (← links)
- Regulatory T Cell targeting in cancer: Emerging strategies in immunotherapy (Q104271729) (← links)
- Human-engineered Treg-like cells suppress FOXP3-deficient T cells but preserve adaptive immune responses <i>in vivo</i> (Q104283078) (← links)